Dissemin is shutting down on January 1st, 2025

Published in

Wiley, American Journal of Hematology, 12(89), p. 1147-1150, 2014

DOI: 10.1002/ajh.23867

Links

Tools

Export citation

Search in Google Scholar

Activated Protein C Resistance Testing for Factor V Leiden

Journal article published in 2014 by Stephan Kadauke, Bernard Khor ORCID, Elizabeth M. Van Cott
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Activated protein C resistance (APC-R) assays can detect factor V Leiden with high accuracy, depending on the method used. Factor Xa inhibitors such as rivaroxaban and direct thrombin inhibitors including dabigatran, argatroban, and bivalirudin can cause falsely normal results. Lupus anticoagulants can cause incorrect results in most current assays. Assays that include dilution into factor V-deficient plasma are needed to avoid interference from factor deficiencies or elevations, which can arise from a wide variety of conditions such as warfarin, liver dysfunction, or pregnancy. The pros and cons of the currently available assays are discussed.